Construction Business Review Conferences
The PharmaMarketing Summit strengthens future-ready commercial strategy by bringing together senior pharma marketing leaders to share actionable insight, challenge legacy approaches and build high-value partnerships. Through focused dialogue on launch excellence, omnichannel engagement, data and AI adoption, and evolving HCP and patient expectations, we help decision-makers improve brand performance, accelerate execution, enhance decision confidence and deliver measurable commercial impact in a complex, regulated market.
The American Biomanufacturing Summit has a rich history as an exclusive platform for biopharma and biotech executives - and as a flagship annual event, it remains a premier biomanufacturing event built for high-level, in-person knowledge exchange and solution exploration.
The AI in Medical Affairs conference examines how artificial intelligence is being applied across medical strategy, evidence generation, scientific communications and field medical operations within pharmaceutical, biotechnology and medical device organizations. Its audience includes medical affairs leaders, digital strategists, data specialists and clinical professionals navigating AI adoption, workforce upskilling, data synthesis and the need to deploy compliant solutions that deliver measurable value. Life Sciences Review’s coverage of scientific innovation, regulatory demands and operational change across pharmaceuticals, biotechnology, medical devices and diagnostics provides a broader context for these developments. Its reporting can follow how generative AI, data-driven decision-making and automation are being implemented in medical functions while examining governance, compliance and practical adoption challenges. Such coverage gives the publication’s professiona
The 2027 Commercial Pharma Summit drives next-generation brand performance by convening elite marketing leaders to dissect disruptive strategies, dismantle legacy barriers, and forge high-impact industry alliances. By targeting critical priorities including modern launch architecture, AI-driven customer intelligence, precision HCP engagement, and shifting patient behaviors - we enable executives to elevate brand positioning, streamline launch workflows and capture measurable market share across dynamic global markets.
The Evolution Summit equips senior clinical leaders to strengthen trial execution amid rapidly evolving technology, regulatory expectations and development models. Through executive case studies, peer benchmarking and closed-door discussion, delegates examine practical AI implementation, patient-centered trial design, ICH E6(R3), global trial strategy and evolving site and CRO partnerships. The program enables leaders to challenge established operating models, identify opportunities to improve speed, quality and efficiency and prepare their organizations for emerging approaches including Real-Time Clinical Trials.
Life science organizations developing cell therapies for autoimmune diseases are under increasing pressure to translate promising clinical results into scalable, commercially viable treatments. While early proof-of-concept studies have demonstrated the transformative potential of approaches such as CAR-T, NK, Treg, MSC, and emerging in vivo therapies, significant challenges remain in target selection, manufacturing scalability, safety management, regulatory alignment, and patient accessibility. As clinical datasets mature and the field expands beyond oncology, developers must establish clear strategies to accelerate development, demonstrate long-term value, and deliver meaningful outcomes for patients. The 4th Cell Therapy for Autoimmune Disease Summit brings together industry leaders to share real-world insights, benchmark best practices, and foster collaborations that will help advance the next generation of autoimmune cell therapies from clinical promise to widespread patient imp
The American Pharma Manufacturing & Outsourcing Summit is a premier executive-level pharma manufacturing and pharma outsourcing conference, bringing together 150+ senior leaders from pharmaceutical manufacturers and leading solution providers.
U.S Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the U.S’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the U.S and the world.
11th BioPharma Supply Chain & Logistics Nexus Conference, happening Nov 11–12, 2026, in San Diego, USA. This invitation-only, executive-level gathering brings together senior leaders from pharmaceutical and life sciences organizations with hand-picked solution providers shaping the future of supply chain management. Designed to move beyond the traditional conference format, the Nexus delivers a multi-dimensional experience focused on knowledge exchange, strategic collaboration, and actionable insights. Explore emerging trends and innovative solutions across advanced cold chain logistics, temperature-controlled distribution, regulatory compliance, sustainability initiatives, warehousing optimization, and inventory management strategies.
Life Sciences Workplace Boston 2026 brings together senior workplace, real estate, HR and technology leaders from life sciences, biotech and healthcare to explore the future of work through people, place and technology.
